Last $1.41 USD
Change Today -0.06 / -4.08%
Volume 40.1K
ELMD On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

electromed inc (ELMD) Snapshot

Open
$1.47
Previous Close
$1.47
Day High
$1.48
Day Low
$1.38
52 Week High
12/31/13 - $3.50
52 Week Low
09/13/13 - $0.90
Market Cap
11.4M
Average Volume 10 Days
33.5K
EPS TTM
$-0.24
Shares Outstanding
8.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ELECTROMED INC (ELMD)

Related News

No related news articles were found.

electromed inc (ELMD) Related Businessweek News

No Related Businessweek News Found

electromed inc (ELMD) Details

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy products. The company offers SmartVest airway clearance system and related products, which generate high frequency chest wall oscillation to patients suffering from cystic fibrosis, bronchiectasis, muscular dystrophy, repeated episodes of pneumonia, post-surgical airway complications, and various other diseases and conditions that are associated with impaired lung and airway capacity. It also provides single patient use SmartVest, a vest that is used for patients undergoing institutional treatment; and SmartVest Wrap for patients recovering from surgery and short-term illnesses. The company markets its products primarily to the home health care and institutional markets through a network of direct sales representatives and independent distributors for use by patients in personal residences, hospitals, clinics, and pulmonary rehabilitation centers in the United States and internationally. Electromed, Inc. was founded in 1992 and is headquartered in New Prague, Minnesota.

87 Employees
Last Reported Date: 09/25/13
Founded in 1992

electromed inc (ELMD) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $122.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $138.1K
Compensation as of Fiscal Year 2013.

electromed inc (ELMD) Key Developments

Darrel Kloeckner Plans to Step Down from the Board of Electromed, Inc

Electromed, Inc. announced that Darrel Kloeckner, a member of the company's Board of Directors will not stand for re-election at the company's 2014 Annual Meeting of shareholders. Mr. Kloeckner has been a member of the Board since 2010.

Electromed, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014

Electromed, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2014. Net revenues in the third quarter of fiscal 2014 were approximately $3.96 million, an approximately 24% increase compared to the same period of fiscal 2013. The company reported a net loss of approximately $1,004,000 or $0.12 per basic and diluted share, for the third quarter of fiscal 2014, compared to a net loss of approximately $431,000, or $0.05 per basic and diluted share, for the same period last year. Operating loss was $217,062 compared with $693,808 a year ago. Net loss before income taxes was $240,383 compared with $722,966 a year ago. For the nine months, the company's net revenues were $10,875,588 compared to $11,086,190 a year ago. Operating loss was $1,103,058 compared with $1,385,592 a year ago. Net loss before income taxes was $1,161,050 compared with $1,477,265 a year ago. Net loss was $1,579,050 or $0.19 per basic and diluted share compared with $913,265 or $0.11 per diluted share a year ago. Net cash provided by operating activities was $1,019,990 compared with $990,187 a year ago. Expenditures for property and equipment were $626,327 compared with $707,140 a year ago. Expenditures for finite-life intangible assets were $8,155 compared with $35,642 a year ago.

Electromed, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2013

Electromed, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended December 31, 2013. Net revenues in the quarter were approximately $3.50 million, a 9% decrease compared to $3.86 million in the same period of fiscal 2013. The company reported a net loss of approximately $0.2 million, or three cents per basic and diluted share, for the second quarter of fiscal 2014, compared to a net loss of approximately $0.4 million, or five cents per basic and diluted share, for the same period of fiscal 2013. The modest decline in total revenues in the second quarter of fiscal 2014 was attributable to lower average prices received from health care insurers due to their increased focus on controlling health care costs as well as more rigorous scrutiny by insurers of reimbursement requests for a wide range of medical devices and other health care products. Net loss before income taxes was $328,262 against $621,191 a year ago. For the six months, the company reported net revenue of $6,919,253, net loss before income taxes of $920,667, net loss of $574,667 or $0.07 per diluted share against net revenue of $7,887,656, net loss before income taxes of $754,299, net loss of $482,299 or $0.06 per diluted share a year ago. Net cash provided by operating activities was $1,131,641 against $1,202,394 a year ago. Expenditures for property and equipment was $291,044 against $482,122 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ELMD:US $1.41 USD -0.06

ELMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ELMD.
View Industry Companies
 

Industry Analysis

ELMD

Industry Average

Valuation ELMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 1.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELECTROMED INC, please visit www.electromed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.